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neous marginal zone b-cell lymphoma
Haematologica 2004; 89:(9)e113
Dear Sir, 
Mucosa-associated lymphoid tissue (MALT) lym-
phomas include low-grade B-cell lymphomas from a
number of extranodal sites, affecting both mucosal
organs such as the salivary gland, lung, thyroid, conjunc-
tiva, and liver and nonmucosal organs such as the orbit
and the skin. These organs are devoid of any native lym-
phoid tissue, and the lymphoma arises from the MALT
acquired as a result of a chronic inflammatory or autoim-
mune disorder.1 Genetically, only 5% of MALT lym-
phomas show the t(1;14)(p22;q32), that causes BCL10
deregulation, which specifically links the antigen receptor
signaling to the NFkB pathway.2 The most frequent struc-
tural abnormality in MALT lymphomas is
t(11;18)(q21;q21), that fuses the amino terminal of the
API2 gene (11q21) to the carboxyl terminal of the MALT1
gene (18q21) and generates a chimeric fusion product
that also activates NFkB.3 This abnormality has been
detected in 30%-50% of gastric MALT lymphomas, and
also in other localizations (small intestine, large intestine,
lung, conjunctiva, orbit and salivary gland) at marked
variable frequencies.4 Recently, Streubel et al reported a
novel recurrent translocation t(14;18)(q32;q21) in MALT
lymphoma involving IgH and MALT1 genes.5 In primary
cutaneous marginal zone B-cell lymphomas (PCMZL),
there is a controversy regarding the existence of MALT1
translocations. Some authors have demonstrated the
absence of  t(11;18)(q21;q21) by polymerase chain reac-
tion (PCR) methods and other MALT1 (18q21) rearrange-
ments by fluorescence in situ hybridization (FISH) tech-
niques4,6 while others have shown the presence of
MALT1 translocations such as t(14;18)(q32;q21)5 in
patients with PCMZL. The aim of the present study was
to determine if PCMZL show MALT1 translocations.
Twenty-six samples from twenty-three patients affect-
ed with a PCMZL were included in the study. Sixteen
were males and seven were females, with a mean age of
46 years. All cases were classified according to the
EORTC and WHO classifications.1,7 The diagnosis was
established taking into account the clinical, cytological
and immunophenotypical and molecular data. FISH was
performed on paraffin sections from the affected skin
areas using a MALT1 (18q21) dual color break apart
translocation probe (VYSIS, Downers Grove, IL) to detect
MALT1 translocations. One hundred nuclei were scored.
In addition, ten peripheral blood samples from healthy
donors were tested with the same FISH probe as controls.
MALT1 translocations were not detected in any of the
analyzed cases. In two paraffin sections from cases with
PCMZL, some areas showed three copies of the MALT1
gene. However, in the control peripheral blood samples
we detected until a 13% of the analyzed nuclei harbour-
ing three copies of the MALT1 gene. Moreover, the find-
ing of three copies of MALT1 gene in normal tissues was
previously described by Krugmann et al.8 when they ana-
lyzed their control samples (five normal gastric mucosa
and ten cases of H pylori associated gastritis) and the cut
of value for the detection of a partial trisomy 18 (of
MALT1 gene) was set at 15% of nuclei with more than
two signals of the probe. 
The implication of MALT1 gene in the pathogenic
pathway of  PCMZL has been a matter of controversy.
Streubel et al.5 studied the presence of the recently
described t(14;18)(q32;q21) IgH/MALT1 in a large series
of 66 MALT lymphomas of different localizations.
Among them, 11 cases were PCMZL. Using a dual color
interphase FISH assay, they found the implication of the
IgH/MALT1 translocation in 3/11 cases (27%). Other
authors have also analyzed the implication of MALT1
gene in the same pathology. Gronbaek et al.6 examined
the presence of t(11;18)(q21;q21) API2/MALT1 transloca-
tion in a series of 19 primary cutaneous B-cell lym-
phomas (PCBCL), being 12 of them PCMZL, by using RT-
PCR technique and none of the cases showed any evi-
dence of API2/MALT1 transcripts indicating that the
t(11;18)(q21;q21) is not a typical feature of PCBCL. In
addition, Ye et al.4 studied the existence of API2/MALT1
translocation by RT-PCR and the presence of MALT1
translocations by FISH in 417 cases of MALT lym-
phomas, 27 of which were PCMZL and did not find
MALT1 implication in any of these cases. In the present
study, we have applied FISH technology with a MALT1
dual color break apart translocation probe that would
detect all the possible translocations affecting MALT1
gene, including t(11;18)(q21;q21) API2/MALT1,
t(14;18)(q32;q21) IgH/MALT1 and others. Our results
agree with those found by Gronbaek et al.6 and Ye et al. 4
and do not confirm the implication of MALT1 gene in
PCMZL found by Streubel et al.5 In conclusion, larger
studies are warranted in order to determine the real inci-
dence of MALT1 translocations in PCMZL.
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